A 12-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease.
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 07 Dec 2012
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors Eisai Medical Research
- 31 Jul 2009 Additional lead trial centre identified as reported by United Kingdom Clinical Research Network record.
- 04 Mar 2009 Identified and integrated new source (United Kingdom Clinical Research Network).
- 23 Jul 2008 New trial record.